Poll shows voters are increasingly informed about drug pricing in the Inflation Reduction Act

SEO Article Rewrite

President Biden’s Efforts to Lower Prescription Drug Costs

President Biden has been actively promoting the Inflation Reduction Act as a means to reduce the cost of prescription drugs. A recent survey by the health policy research group KFF reveals that while his message is gaining traction, many voters remain unaware of important provisions within the act.

Key Provisions of the IRA

Biden’s focus on lowering health costs has been a central theme of his administration. The successful passage of the IRA has been highlighted as one of his significant achievements.

Awareness Among Older Voters

The survey found that awareness of the IRA is highest among voters aged 65 and above, particularly those covered by Medicare. This demographic group, known for higher voter turnout, is more informed about the $35 cap on insulin for Medicare beneficiaries.

Among older voters, 48 percent are aware of the law mandating the federal government to negotiate prescription drug prices for Medicare enrollees, compared to only a third of all voters.

Increasing Awareness

While overall awareness of the IRA’s Medicare drug pricing provisions has not significantly changed, there has been a notable increase in awareness among Democratic voters and older demographics. This positive trend suggests that efforts to communicate the benefits of the IRA are making progress.

Despite these gains, the survey indicates that there are still considerable challenges in raising awareness about the IRA’s provisions among the general population.

Public Support and Perception

A large bipartisan majority of voters express support for extending the IRA’s drug provisions to cover all adults with private insurance. This includes measures like capping monthly insulin costs and limiting out-of-pocket expenses for prescription drugs.

While there is public support for Biden’s proposals, most voters remain skeptical about the potential impact of either candidate on drug pricing. Independent voters slightly favor Biden’s ability to lower prescription drug costs if elected.

Trust in Candidates

When it comes to addressing high healthcare costs, neither Biden nor Trump have a clear advantage in public trust. The survey indicates a close split between the two candidates in terms of voter confidence in tackling healthcare expenses.

Survey Details

The survey was conducted from April 23 to May 1 and involved a nationally representative sample of 1,479 U.S. adults. The margin of error for the full sample is plus or minus 3 percentage points, and for registered voters, it is plus or minus 4 percentage points.

Copyright 2024 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Read More of this Story at thehill.com – 2024-05-15 19:16:00

Read More US Economic News

Leave A Reply

Your email address will not be published.